Northwell Names New System Director of Thoracic Surgery

Paul C. Lee, MD, MPH

Northwell Health today announced that Paul C. Lee, MD, MPH, has been appointed system director of thoracic surgery and director of Northwell’s Comprehensive Lung and Foregut Center. With practice locations in Great Neck and at Lenox Hill Hospital, Dr. Lee has 15 years of experience as a thoracic surgeon and specializes in treating lung and esophageal cancers, and other thoracic disorders.

Before joining Northwell Health, Dr. Lee held several clinical leadership roles at New York-Presbyterian/Queens, including vice chair of cardiothoracic surgery and chief of thoracic surgery. In addition, he was a cardiothoracic surgeon at New York-Presbyterian Hospital/Cornell Campus and a professor of cardiothoracic surgery at the Weill Cornell Medical College.

Dr. Lee received a bachelor’s degree from Harvard College in Cambridge, MA; his medical degree from Johns Hopkins School of Medicine in Baltimore, MD; and a master’s in healthcare management from Columbia University Mailman School of Public Health.  He completed his general surgery residency at the University of Pittsburgh Medical Center and his cardiothoracic surgery residency at the New York-Presbyterian Hospital/Weill Cornell University Medical Center and the Memorial Sloan-Kettering Cancer Center.  During this time, Dr. Lee received additional training in minimally invasive thoracoscopic surgery at the University of Pittsburgh.

Board-certified in surgery and thoracic surgery, Dr. Lee is a member of various medical societies including the American College of Surgeons, the American College of Chest Physicians, Society of Thoracic Surgeons and the American Society of Clinical Oncology. Dr. Lee will serve on the faculty of the Hofstra Northwell School of Medicine as professor of cardiovascular and thoracic surgery.

Dr. Lee has published more than 100 peer-reviewed articles and has given presentations at many national scientific meetings in the fields of cardiopulmonary physiology, molecular cell biology and thoracic oncology. Dr. Lee is currently involved as the principle investigator of several innovative biological research trials for the treatment of lung and esophageal cancer. 

Dr. Lee speaks fluent Mandarin and Cantonese and has done extensive volunteer work to improve the health status of the underserved population in the New York City community. He is the current president of the Chinese American Medical Society.